An Oral PAMORA Effective for Constipation in Cancer

Share this post

For the first time, there are phase 3 clinical trial data on a peripherally acting mu-opioid receptor antagonist (PAMORA) for opioid-induced constipation in cancer patients.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply